The TGR(mRen2)27 transgenic rat model of hypertension
- PMID: 9809790
- DOI: 10.1016/s0167-0115(98)00120-7
The TGR(mRen2)27 transgenic rat model of hypertension
Similar articles
-
Angiotensin II receptor blockade in TGR(mREN2)27: effects of renin-angiotensin-system gene expression and cardiovascular functions.J Hypertens. 1995 Aug;13(8):891-9. doi: 10.1097/00004872-199508000-00010. J Hypertens. 1995. PMID: 8557967
-
Transgenic rats carrying the mouse renin gene--morphological characterization of a low-renin hypertension model.Kidney Int. 1992 Jan;41(1):24-36. doi: 10.1038/ki.1992.4. Kidney Int. 1992. PMID: 1593860
-
The renin-angiotensin system and renal function in transgenic (mRen2)27 rats.Exp Nephrol. 1996;4 Suppl 1:20-6. Exp Nephrol. 1996. PMID: 9001893
-
Physiological characterization of the hypertensive transgenic rat TGR(mREN2)27.Am J Physiol. 1996 Jun;270(6 Pt 1):E919-29. doi: 10.1152/ajpendo.1996.270.6.E919. Am J Physiol. 1996. PMID: 8764174 Review.
-
Transgenic rats: tools to study the function of the renin-angiotensin system.Clin Exp Pharmacol Physiol Suppl. 1996;3:S81-7. Clin Exp Pharmacol Physiol Suppl. 1996. PMID: 8993844 Review.
Cited by
-
Breeding Characteristics and Dose-dependent Blood Pressure Responses of Transgenic Cyp1a1-Ren2 Rats.Comp Med. 2018 Oct 1;68(5):360-366. doi: 10.30802/AALAS-CM-17-18000026. Epub 2018 Sep 5. Comp Med. 2018. PMID: 30185285 Free PMC article.
-
Effects of Finerenone Combined with Empagliflozin in a Model of Hypertension-Induced End-Organ Damage.Am J Nephrol. 2021;52(8):642-652. doi: 10.1159/000516213. Epub 2021 Jun 10. Am J Nephrol. 2021. PMID: 34111864 Free PMC article.
-
Angiotensin-converting enzyme is a modifier of hypertensive end organ damage.J Biol Chem. 2009 Jun 5;284(23):15564-72. doi: 10.1074/jbc.M806584200. Epub 2009 Mar 23. J Biol Chem. 2009. PMID: 19307186 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical